Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Louisville. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 628,594. Kentucky Medicare wound biologics: CGS Administrators (J15). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Louisville clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Louisville storefront.
Build Your Biologic Treatment Center in Louisville, KY for clinics & physicians. Start or expand your biol… Compliance support & pricing — contact Hawk Medical.
CDC PLACES does not publish an arthritis rate for Louisville. Plan joint volume from your referral mix, not a made-up city figure. CDC PLACES does not publish a city-level diabetes row for Louisville. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Together those PLACES numbers are why a city of 500k–1M still needs separate PRP and CTP protocols. biologic treatment center inventory is national; utilization is J15-local.
National Build Your Biologic Treatment Center notes (how the product actually works)J15 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Louisville is unpublished at place grain or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, J15 articles mapped. We do not have a CDC PLACES uninsured rate for Louisville. Expect a mix of J15 fee-for-service, Advantage, workers’ comp, and cash-pay, and price them as separate tickets. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES has no incorporated-place row we could match for Louisville. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
Kentucky is in CMS MAC J15, administered by CGS Administrators. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Kentucky compliance risk.
We source from FDA-registered banks. Bank location is not the same as Hawk Medical’s distribution address, and it is not a Louisville clinic. Ask for the bank’s registration and AATB status on the SKU you want.
Ask for the IFU, the lot-traceability packet, and the CGS Administrators article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Louisville fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Louisville, KY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Louisville is J15 geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Kentucky Part B wound biologics follow this contractor (siblings: OH). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 500k–1M, not a count of orthopedic groups.
No Louisville storefront. Joe Bradley is an active practice owner. biologic treatment center stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.